CYT - Cyteir Therapeutics GAAP EPS of -$0.34 August, 08 2022 05:28 PM Cyteir Therapeutics Inc. Cyteir Therapeutics press release ( NASDAQ: CYT ): Q2 GAAP EPS of -$0.34. Cash and cash equivalents as of June 30, 2022 were $166.4 million. For further details see: Cyteir Therapeutics GAAP EPS of -$0.34